Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: LMAT

LeMaitre Vascular, Inc.

Healthcare | Medical - Instruments & Supplies

No licensed closing price on file for LMAT. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$2.86

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-20 05:59 UTC.

What LeMaitre Vascular, Inc. does

The company develops, manufactures, and markets medical devices and human tissue cryopreservation services for treating peripheral vascular disease, end-stage renal disease, and cardiovascular disease. Its product portfolio includes vascular devices used in arteries and veins, sold primarily through a direct sales force in the United States, Europe, Canada, and Asia Pacific, with headquarters in Burlington, Massachusetts. The company estimates the worldwide peripheral vascular device market exceeds a certain value, with its products capturing a portion of this market.

Summarized from LeMaitre Vascular, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$2.86
Return on equity14.67%

Revenue, margins & earnings

FY2021 Net income: $27MFY2021 Taxes & interest: $10MFY2021 Operating expenses: $65MFY2021 Cost of revenue: $53M$154MFY2021FY2022 Net income: $21MFY2022 Taxes & interest: $6MFY2022 Operating expenses: $78MFY2022 Cost of revenue: $57M$162MFY2022FY2023 Net income: $30MFY2023 Taxes & interest: $7MFY2023 Operating expenses: $90MFY2023 Cost of revenue: $66M$193MFY2023FY2024 Net income: $44MFY2024 Taxes & interest: $8MFY2024 Operating expenses: $99MFY2024 Cost of revenue: $69M$220MFY2024FY2025 Net income: $58MFY2025 Taxes & interest: $10MFY2025 Operating expenses: $111MFY2025 Cost of revenue: $71M$250MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-08
  • 2026-09-08President and DirectorDividend Equivalent RightsAward3—
  • 2026-09-08President and DirectorDividend Equivalent RightsAward0—
  • 2026-09-08DirectorDividend Equivalent RightsAward3—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does LeMaitre Vascular, Inc. do?

The company develops, manufactures, and markets medical devices and human tissue cryopreservation services for treating peripheral vascular disease, end-stage renal disease, and cardiovascular disease.

When did LMAT last file with the SEC?

LeMaitre Vascular, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:59 UTC. This page is also available as JSON at /api/data?ticker=LMAT and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for LMAT and 5,000+ tickers.

Create a free account — keep LMAT
For your agent
GET /api/data?ticker=LMAT

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt